\u798f\u6cf0\u5236\u836fVertex Pharmaceuticals\uff08NASDAQ:VRTX\uff09<\/a>\u7684CRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5Casgevy\uff0c\u4ee5\u53caBluebird bio Inc\uff08NASDAQ:BLUE\uff09\u5f00\u53d1\u7684Lyfgenia\u3002\u6b64\u5916\uff0cEditas Medicine\uff08NASDAQ:EDIT\uff09\u76ee\u524d\u6b63\u5728\u8fdb\u884c\u5176CRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5Reni-Cel\u548cEdiTHAL\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002Intellia Therapeutics\uff08NASDAQ:NTLA\uff09\u7684\u7814\u53d1\u7ba1\u7ebf\u4e5f\u5305\u62ec\u591a\u79cdCRISPR\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u3002<\/p>\n\u5728\u7ec4\u7ec7\u5de5\u7a0b\u6216\u751f\u7269\u6253\u5370\u4e2d\uff0cCRISPR\u6280\u672f\u8fd8\u53ef\u7528\u4e8e\u4fee\u6539\u7ec6\u80de\uff0c\u521b\u9020\u51fa\u7528\u4e8e\u79fb\u690d\u7b49\u6cbb\u7597\u76ee\u7684\u7684\u4e2a\u6027\u5316\u7684\u7ec4\u7ec7\u548c\u5668\u5b98\u3002\u6700\u8fd1\uff0c\u52a0\u62ff\u5927\u7814\u7a76\u56e2\u961f\u5f00\u53d1\u7684\u4fbf\u643a\u5f0f\u751f\u7269\u6253\u5370\u8bbe\u5907\u53ef\u4ee5\u5728\u4eba\u4f53\u5185\u6253\u5370\u751f\u7269\u76f8\u5bb9\u7ed3\u6784\u3002<\/p>\n
\u764c\u75c7\u514d\u75ab\u7597\u6cd5<\/h2>\n
\u8fd1\u5e74\u6765\uff0c\u764c\u75c7\u514d\u75ab\u6cbb\u7597\u9886\u57df\u53d6\u5f97\u4e86\u91cd\u8981\u8fdb\u5c55\uff0c\u8fd9\u90e8\u5206\u5f52\u529f\u4e8e\u7c7b\u4f3cCAR-T\u7ec6\u80de\u7597\u6cd5\u7b49\u751f\u7269\u6280\u672f\u7684\u8fdb\u6b65\u3002\u867d\u7136CAR-T\u7597\u6cd5\u4ecd\u5904\u4e8e\u65e9\u671f\u9636\u6bb5\uff0c\u4f46\u5b83\u662f\u764c\u75c7\u514d\u75ab\u6cbb\u7597\u4e2d\u4e00\u4e2a\u5907\u53d7\u5173\u6ce8\u7684\u6709\u524d\u9014\u7684\u9886\u57df\u3002BioInformant\u76842024\u5e74CAR-T\u878d\u8d44\u62a5\u544a\u663e\u793a\uff0c\u5728\u8fc7\u53bb\u768410\u5e74\u91cc\uff0c\u4ece\u4e8bCAR-T\u7597\u6cd5\u7684\u516c\u53f8\u5171\u5438\u5f15\u4e8667\u4ebf\u7f8e\u5143\u7684\u98ce\u9669\u6295\u8d44\uff0c\u5e76\u901a\u8fc7\u9996\u6b21\u516c\u5f00\u53d1\u884c\u7b79\u96c6\u4e8657.6\u4ebf\u7f8e\u5143\u3002\u5c3d\u7ba1FDA\u5df2\u7ecf\u6279\u51c6\u4e866\u6b3eCAR-T\u7597\u6cd5\uff0c\u4f46\u98ce\u9669\u95ee\u9898\u662f\u4e00\u4e2a\u9690\u5fe7\u3002<\/p>\n
\u77ed\u671f\u4e4b\u5185\uff0c\u6297\u4f53\u836f\u7269\u5076\u8054\u7269\uff08ADCs\uff09\u5c06\u4f1a\u6709\u66f4\u591a\u7684\u63a2\u7d22\u3002\u6bd4\u5982\u8bf4\uff0c\u7f57\u6c0fRoche\uff08OTCQX:RHHBF, SWX:RO\uff09\u5b50\u516c\u53f8\u57fa\u56e0\u6cf0\u514b\u76ee\u524d\u6b63\u5728\u7814\u7a76\u57fa\u4e8e\u6297\u4f53\u7684\u836f\u7269tiragolumab\u4e0eTecentriq\u8054\u5408\u4f7f\u7528\u65f6\u7684\u6709\u6548\u6027\u3002\u5409\u5229\u5fb7\u79d1\u5b66Gilead Sciences\uff08NASDAQ:GILD\uff09\u662f\u53e6\u4e00\u5bb6\u5728\u5f00\u53d1ADC\u7597\u6cd5\u7684\u516c\u53f8\uff0c\u76ee\u524d\u6b63\u5728\u8fdb\u884c\u80ba\u764c\u7597\u6cd5\u7684III\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n
\u751f\u7269\u79d1\u6280\u5728\u519c\u4e1a\u9886\u57df\u7684\u5e94\u7528<\/h2>\n
2023\u5e7411\u6708\uff0c\u4e16\u754c\u9886\u8896\u9f50\u805aCOP28\u8ba8\u8bba\u6c14\u5019\u5371\u673a\u548c\u53ef\u6301\u7eed\u7cae\u98df\u7cfb\u7edf\u7684\u89e3\u51b3\u65b9\u6848\uff0c\u4e00\u4e9b\u4e13\u5bb6\u63d0\u51fa\u751f\u7269\u6280\u672f\u53ef\u80fd\u6210\u4e3a\u519c\u4e1a\u521b\u65b0\u89e3\u51b3\u65b9\u6848\u7684\u6f5c\u5728\u6765\u6e90\u3002\u8f6c\u57fa\u56e0\u4f5c\u7269\u5177\u6709\u589e\u52a0\u4ea7\u91cf\uff0c\u63d0\u9ad8\u8425\u517b\u4ef7\u503c\u4ee5\u53ca\u62b5\u6297\u6c14\u5019\u53d8\u5316\u7684\u6f5c\u529b\uff0c\u6709\u53ef\u80fd\u5728\u89e3\u51b3\u5168\u7403\u7cae\u98df\u5371\u673a\u4e2d\u626e\u6f14\u91cd\u8981\u89d2\u8272\u3002<\/p>\n
\u751f\u7269\u6280\u672f\u7684\u521b\u65b0\u63a8\u52a8\u4e86\u7cbe\u51c6\u519c\u4e1a\u548c\u7acb\u4f53\u519c\u4e1a\u7684\u53d1\u5c55\uff0c\u65e0\u4eba\u673a\u548c\u4f20\u611f\u5668\u7b49\u6280\u672f\u7684\u5e94\u7528\u53ef\u4ee5\u4f18\u5316\u519c\u4e1a\u79cd\u690d\uff0c\u51cf\u5c11\u519c\u836f\u548c\u5316\u80a5\u7684\u4f7f\u7528\u3002\u6b64\u5916\uff0c\u7ec6\u80de\u519c\u4e1a\u662f\u751f\u7269\u6280\u672f\u7684\u4e00\u79cd\u5f62\u5f0f\uff0c\u79d1\u5b66\u5bb6\u4eec\u5df2\u7ecf\u80fd\u591f\u751f\u4ea7\u5b9e\u9a8c\u5ba4\u57f9\u517b\u7684\u8089\u7c7b\u548c\u4e73\u5236\u54c1\u3002\u5c3d\u7ba1\u8fd8\u5904\u4e8e\u65e9\u671f\u9636\u6bb5\uff0c\u4f46\u5b83\u6709\u671b\u51cf\u8f7b\u52a8\u7269\u4ea7\u54c1\u7684\u9700\u6c42\u7ed9\u4f20\u7edf\u519c\u573a\u5e26\u6765\u7684\u538b\u529b\u3002\u6700\u540e\uff0c\u5408\u6210\u751f\u7269\u5b66\u53ef\u4ee5\u5e94\u7528\u4e8e\u521b\u9020\u975e\u751f\u7269\u53ef\u964d\u89e3\u6750\u6599\u7684\u751f\u7269\u66ff\u4ee3\u54c1\uff0c\u4ee5\u53ca\u901a\u8fc7\u57fa\u56e0\u5de5\u7a0b\u5fae\u751f\u7269\u534f\u52a9\u751f\u7269\u4fee\u590d\u3002<\/p>\n
\u5176\u4ed6\u503c\u5f97\u5173\u6ce8\u7684\u7ecf\u6d4e\u56e0\u7d20<\/h2>\n
\u53bb\u5e7411\u6708\u548c12\u6708\uff0c\u751f\u7269\u79d1\u6280\u9886\u57df\u522e\u8d77\u5e76\u8d2d\u98ce\u6f6e\uff0c\u5176\u4e2d12\u6708\u76845\u8d77\u5e76\u8d2d\u4e3a\u533b\u7597\u7c7b\u57fa\u91d1\u6ce8\u5165300\u4ebf\u7f8e\u5143\u7684\u8d44\u91d1\u3002\u53bb\u5e7410\u5927\u751f\u7269\u79d1\u6280\u6295\u8d44\u4ea4\u6613\u5f53\u4e2d\uff0c6\u5b97\u53d1\u751f\u5728\u56db\u5b63\u5ea6\uff0c\u5176\u4e2d4\u5b97\u5b8c\u6210\u4e8e2023\u5e74\u7684\u6700\u540e5\u5468\uff0c\u6700\u53d7\u5173\u6ce8\u7684\u751f\u7269\u79d1\u6280\u5e76\u8d2d\u5305\u62ec\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09101\u4ebf\u7f8e\u5143\u6536\u8d2dImmunogen Inc\uff08NASDAQ:IMGN\uff09\uff0c\u4ee5\u53ca87\u4ebf\u7f8e\u5143\u6536\u8d2dCerevel Therapeutics\u7684\u8ba1\u5212\u3002<\/p>\n
12\u670813\u65e5\uff0c\u7f8e\u8054\u50a8\u4e3b\u5e2d\u9c8d\u5a01\u5c14\u7684\u8bb2\u8bdd\u63d0\u5347\u4e862024\u5e74\u964d\u606f\u7684\u9884\u671f\uff0c\u8fd9\u6216\u8bb8\u6fc0\u53d1\u4e86\u65b0\u4e00\u8f6e\u7684\u5e76\u8d2d\uff0c\u6bd4\u5982\u8bf412\u670822\u65e5\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9dBristol-Myers Squibb\uff08NYSE:BMY\uff09\u5ba3\u5e03140\u4ebf\u7f8e\u5143\u6536\u8d2dKaruna Therapeutics Inc\uff08NASDAQ:KRTX\uff09\uff0c\u4ee5\u53ca4\u5929\u540eRayzeBio (NASDAQ:RYZB)\u5ba3\u5e0341\u4ebf\u7f8e\u5143\u7684\u6536\u8d2d\u3002\u7f8e\u8054\u50a8\u4f1a\u8bae\u4ee5\u6765\u622a\u81f31\u670817\u65e5\uff0cSPDR S&P Biotech ETF\uff08ARCA:XBI\uff09\u4e0a\u6da88.26%\u3002<\/p>\n
\u5c55\u671b2024\u5e74\uff0c\u5b89\u6c38\u62ab\u9732\u79f0\u524d25\u5927\u751f\u7269\u5236\u836f\u516c\u53f8\u62e5\u67091.37\u4e07\u4ebf\u7f8e\u5143\u7684\u8d44\u91d1\u7528\u4e8e\u5bfb\u6c42\u589e\u957f\u673a\u4f1a\uff0c\u5f62\u5f0f\u5305\u62ec\u5e76\u8d2d\u53ca\u5176\u4ed6\u6218\u7565\u6295\u8d44\u3002\u6b64\u5916\uff0c2024\u5e74\u8fc4\u4eca\uff0c\u5df2\u7ecf\u67095\u5bb6\u751f\u7269\u79d1\u6280\u516c\u53f8\u5ba3\u5e03IPO\uff0c\u6bd4\u5982\u8bf4\u6700\u8fd1\u7684Kyverna Therapeutics\u3002\u76f8\u6bd42023\u5e74\u5168\u5e74\uff0c\u6574\u4e2a\u751f\u7269\u79d1\u6280\u9886\u57df\u7684IPO\u6570\u91cf\u53ea\u6709\u53ef\u601c\u768419\u4e2a\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u867d\u7136\u8fc7\u53bb\u4e00\u5e74\u751f\u7269\u79d1\u6280\u80a1\u7968\u8868\u73b0\u4e0d\u4f73\uff0c\u4f46\u8fd9\u4e2a\u884c\u4e1a\u7684\u589e\u957f\u6f5c\u529b\u5e76\u672a\u53d1\u751f\u6539\u53d8\u3002\u6309\u7167Grandview Research\u7684 […]<\/p>\n","protected":false},"author":27,"featured_media":484272,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[526,455,747,925],"class_list":["post-484271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-526","tag-455","tag-747","tag-925","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/484271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=484271"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/484271\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/484272"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=484271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=484271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=484271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}